International Stem Cell Corp Share Price OTC Bulletin Board
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2022 | 8.18M 642M | Sales 2023 | 7.79M 611M | Capitalization | 496K 38.96M |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | - 0 | EV / Sales 2022 | 0.61 x |
Net Debt 2022 | 3.53M 277M | Net Debt 2023 | 2.59M 203M | EV / Sales 2023 | 0.4 x |
P/E ratio 2022 |
-4.35
x | P/E ratio 2023 |
-3.79
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 27.91% |
Managers | Title | Age | Since |
---|---|---|---|
Andrey Semechkin
CEO | Chief Executive Officer | 64 | 30/11/08 |
Russell Kern
DFI | Director of Finance/CFO | 38 | 30/09/08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Russell Kern
DFI | Director of Finance/CFO | 38 | 30/09/08 |
Paul Maier
BRD | Director/Board Member | 76 | 30/06/07 |
Andrey Semechkin
CEO | Chief Executive Officer | 64 | 30/11/08 |
1st Jan change | Capi. | |
---|---|---|
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |